Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa [PDF]
, 2023 Few studies from Africa have described the clinical impact of co-infections on SARS-CoV-2 infection. Here, we investigate the presentation and outcome of SARS-CoV-2 infection in an African setting of high HIV-1 and tuberculosis prevalence by an ...
Abrahams, F +47 more
core
Пошук потенційних інгібіторів SARS-CoV-2 за допомогою in silico методів [PDF]
, 2023 Aim. Using in silico technologies to search for potential SARS-CoV-2 inhibitors among novel tetracyclic ring systems, which are the common core of Crinipellin.Materials and methods.
Fedosov, Andrii I. +7 more
core +2 more sources
A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters [PDF]
, 2021 The development of an effective vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), is a global priority.
Adams, Lucas J +15 more
core +2 more sources
Gastrointestinal SARS CoV-2 Infection and The Dynamic of Its Detection in Stool [PDF]
, 2020 Introduction: SARS-CoV-2 has been strongly associated with respiratory illnesses however the SARS-CoV-2 infection of the gastrointestinal tract is not fully clear.
Abbas, Mohammed +5 more
core +1 more source
The Importance of Research on the Origin of SARS-CoV-2 [PDF]
, 2020 The origin of the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) virus causing the COVID-19 pandemic has not yet been fully determined. Despite the consensus about the SARS-CoV-2 origin from bat CoV RaTG13, discrepancy to host tropism to ...
Adadi, Parise +16 more
core +1 more source
International Prevalence and Mechanisms of SARS-CoV-2 in Childhood Arterial Ischemic Stroke During the COVID-19 Pandemic [PDF]
, 2022 BACKGROUND: Data from the early pandemic revealed that 0.62% of children hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had an acute arterial ischemic stroke (AIS).
Agner, Shannon C +19 more
core +2 more sources
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans [PDF]
, 2020 Zoonotic introduction of novel coronaviruses may encounter preexisting immunity in humans. Using diverse assays for antibodies recognizing SARS-CoV-2 proteins, we detect preexisting humoral immunity.
Agua-Doce, A +46 more
core
Algoritmes de tractament dels pacients amb infecció per SARS-CoV-2 [PDF]
, 2021 Coronavirus SARS-Cov-2; COVID-19; 2019-nCoV; Algoritme; Detecció; Tractament; Atenció primària; Hospital; ResidènciaCoronavirus SARS-Cov-2; COVID-19; 2019-nCoV; Algoritmo; Detección; Tratamiento; Atención primaria; Hospital; ResidenciaCoronavirus SARS ...
Comissió Assessora per al Tractament de la Infecció per SARS-CoV-2
core +1 more source
European multicenter evaluation of Xpert® Xpress SARS-CoV-2/Flu/RSV test [PDF]
, 2021 Rapid diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are paramount for reducing the spread of the current pandemic. During additional seasonal epidemics with influenza A/B and respiratory syncytial virus (RSV), the clinical ...
Fébreau, Christine +9 more
core +1 more source
SARS-CoV-2 aberrantly elevates mitochondrial bioenergetics to induce robust virus propagation [PDF]
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a 'highly transmissible respiratory pathogen, leading to severe multi-organ damage. However, knowledge regarding SARS-CoV-2-induced cellular alterations is limited.
Jun, Sangmi +12 more
core +1 more source